(Q48178552)

9 February 2018

title

Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients. (English)

1 reference

9 February 2018

0 references

1 reference

3

L Klimek

1 reference

9 February 2018

Oliver Pfaar

1

object named as

O Pfaar

1 reference

9 February 2018

author name string

T Biedermann

2

1 reference

9 February 2018

A Sager

4

1 reference

9 February 2018

D S Robinson

5

1 reference

9 February 2018

publication date

2 September 2013

1 reference

9 February 2018

published in

Allergy

1 reference

9 February 2018

volume

68

1 reference

9 February 2018

issue

10

1 reference

9 February 2018

page(s)

1306-1313

1 reference

9 February 2018

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

cites work

1 reference

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

21 January 2018

1 reference

Dynamic evolution of serum immunoglobulin E to airborne allergens throughout childhood: results from the Multi-Centre Allergy Study birth cohort

21 January 2018

1 reference

Allergen immunotherapy: a practice parameter third update.

21 January 2018

1 reference

Safety of a depigmented, polymerized vaccine for the treatment of allergic rhinoconjunctivitis and allergic asthma

21 January 2018

1 reference

Allergen-specific immunotherapy: which outcome measures are useful in monitoring clinical trials?

21 January 2018

1 reference

Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines.

21 January 2018

1 reference

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

21 January 2018

1 reference

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

21 January 2018

1 reference

Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials.

21 January 2018

1 reference

Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence.

21 January 2018

1 reference

Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. I. Efficacy estimated by a model reducing the bias of annual differences in pollen counts.

21 January 2018

1 reference

How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.

21 January 2018

1 reference

A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ALL.12219

1 reference

9 February 2018

release_m4qworws2zeffkq64gwrxvksby

Fatcat ID

0 references

1 reference

9 February 2018